Hematology, transfusion and cell therapy最新文献

Influence of hydroxyurea on tubular phosphate handling in sickle cell nephropathy 羟基脲对镰状细胞肾病患者肾小管磷酸盐处理的影响

Hematology, transfusion and cell therapy Pub Date : 2024-02-01 DOI: 10.1016/j.htct.2023.11.015

Gabriela Araujo de Abreu, Duaran Lopes de Sousa, Suzzy Maria Carvalho Dantas, Alice Maria Costa Martins, T. L. Sampaio, R. Lemes

引用次数: 0

HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies HLA-DR-DQ 关联与 PLASMIC 评分相结合，是获得性血栓性血小板减少性紫癜（aTTP）的可靠预测指标，有助于区分 aTTP 和其他血栓性微血管病

Hematology, transfusion and cell therapy Pub Date : 2024-02-01 DOI: 10.1016/j.htct.2023.11.016

Soumya Pandey, Akul Shrivastava, Y. Harville, Michele Cottler-Fox, T. Harville

引用次数: 0

Anti-PF4 antibodies and their relationship with COVID infection 抗 PF4 抗体及其与 COVID 感染的关系

Hematology, transfusion and cell therapy Pub Date : 2024-02-01 DOI: 10.1016/j.htct.2023.11.012

Chieh Yang, Irene Wang, Akshit Chitkara, Jibin Swankutty, Rushin Patel, Samir V Kubba

引用次数: 0

Hemorrhagic code protocol, a successful case in the patient blood management model for patients with severe hemorrhages 出血代码协议--严重出血患者血液管理模式的成功案例

Hematology, transfusion and cell therapy Pub Date : 2024-02-01 DOI: 10.1016/j.htct.2024.01.002

João Carlos de Campos Guerra, Michele Jaures, Roseny dos Reis Rodrigues, A. Cypriano, D. Malheiro, Anna Carolina Batista Dantas, Fernanda Paulino Fernandes, Neila Maria Marques Negrini, V. Teich

引用次数: 0

Epidemiology, patient journey and unmet needs related to hemophilia in Brazil: a scoping review with evidence map 巴西与血友病有关的流行病学、患者历程和未满足的需求：附有证据地图的范围界定审查

Hematology, transfusion and cell therapy Pub Date : 2024-02-01 DOI: 10.1016/j.htct.2023.12.004

N. B. Schneider, C. L. P. de Araujo, Harryson Wings Godoy dos Santos, Simone Lima, Maicon Falavigna, D. Pachito

引用次数: 0

Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma. 评估霍奇金淋巴瘤患者的 C 反应蛋白及其与预后的关系。

Hematology, transfusion and cell therapy Pub Date : 2024-01-20 DOI: 10.1016/j.htct.2023.11.011

Elizete Aparecida da Silva Negreiros, Talita Máira Bueno da Silveira, Sérgio Costa Fortier, Carlos Sérgio Chiattone

{"title":"Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma.","authors":"Elizete Aparecida da Silva Negreiros, Talita Máira Bueno da Silveira, Sérgio Costa Fortier, Carlos Sérgio Chiattone","doi":"10.1016/j.htct.2023.11.011","DOIUrl":"https://doi.org/10.1016/j.htct.2023.11.011","url":null,"abstract":"Objectives: To assess the prognostic value of C-Reactive Protein (CRP), at diagnosis and during follow-up, of patients with Hodgkin´s Lymphoma treated at the Hematology Service of the Santa Casa de São Paulo Hospital, and to correlate serum CRP levels with disease stage and treatment response.Methods: A retrospective study involving review of 71 medical records of patients diagnosed with Hodgkin´s Lymphoma between February 2012 and January 2016 was performed. Three patients were subsequently excluded, giving a total of 68 patients for analysis. A level of CRP > 1mg/dl was considered elevated.Results: Patients were predominantly male (61.8%) and mean age was 34 years. Fifty-three (78%) patients had advanced stage and (76.5%) had B symptoms. Elevated baseline CRP was associated with greater likelihood of B symptoms (p= 0.02) and of advanced stage (p= 0.015). Patients with Low CRP level after 5th and 6th cycles of chemotherapy was associated with complete response (p=0.04 and p=0.03, respectively). Treatment-refractory patients had greater risk of death (p=0.002).Conclusion: CRP is clinically important for follow-up of patients with Hodgkin´s Lymphoma, where high levels were associated with advanced disease and/or presence of B symptoms. CRP level was considered a predictor of treatment response. Persistence of high CRP values during treatment was associated with refractoriness.","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139673915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0